Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Leukemia Myelogenous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00003294
What this trial is testing

Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer

Who this might be right for
LeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Roswell Park Cancer Institute 24
Testing effectiveness (Phase 2)Study completedNCT02743351
What this trial is testing

Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+3 more
Fate Therapeutics 96
Testing effectiveness (Phase 2)Ended earlyNCT01500161
What this trial is testing

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more
Texas Oncology Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT06815003
What this trial is testing

Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia+3 more
City of Hope Medical Center 35
Not applicableWithdrawnNCT00038870
What this trial is testing

Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes

Who this might be right for
Acute Myelogenous LeukemiaChronic Myelogenous Leukemia
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00006251
What this trial is testing

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer

Who this might be right for
Acute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more
Fred Hutchinson Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT00003727
What this trial is testing

Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
University of Maryland, Baltimore 22
Early research (Phase 1)Study completedNCT03814005
What this trial is testing

Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute+3 more
Takeda 17
Large-scale testing (Phase 3)Study completedNCT00481247
What this trial is testing

A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Who this might be right for
Myeloid Leukemia, Chronic
Bristol-Myers Squibb 547
Early research (Phase 1)Study completedNCT01834248
What this trial is testing

DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAlkylating Agent-Related Acute Myeloid LeukemiaChronic Myelomonocytic Leukemia+2 more
Roswell Park Cancer Institute 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07493408
What this trial is testing

Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML

Who this might be right for
Ph+ Acute Lymphoblastic Leukemia (Ph+ALL)Blastic Transformation of Chronic Myeloid LeukemiaPhiladelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (Ph+ B-ALL)+1 more
The University of Hong Kong
Large-scale testing (Phase 3)Not Yet RecruitingNCT07489755
What this trial is testing

TGRX-678 Chinese Phase III in Chronic Myelogenous Leukemia (CML) Patients

Who this might be right for
Chronic Myelogenous LeukemiaChronic Myelogenous Leukemia - Chronic Phase
Shenzhen TargetRx Co., Ltd. 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT01522976
What this trial is testing

Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Who this might be right for
Chronic Myelomonocytic LeukemiaChronic Myelomonocytic Leukemia-1Chronic Myelomonocytic Leukemia-2+4 more
National Cancer Institute (NCI) 282
Testing effectiveness (Phase 2)WithdrawnNCT04282174
What this trial is testing

CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies

Who this might be right for
Hematologic DiseasesHematologic MalignancyAcute Lymphoblastic Leukemia+3 more
Baptist Health South Florida
Large-scale testing (Phase 3)UnknownNCT01217723
What this trial is testing

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

Who this might be right for
Hematologic Malignancies
McMaster University 198
Testing effectiveness (Phase 2)WithdrawnNCT00162513
What this trial is testing

Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Hadassah Medical Organization
Testing effectiveness (Phase 2)Ended earlyNCT01045382
What this trial is testing

MSC and HSC Coinfusion in Mismatched Minitransplants

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, AcuteLeukemia, Myelocytic, Chronic+6 more
University of Liege 39
Testing effectiveness (Phase 2)Looking for participantsNCT03999723
What this trial is testing

Combining Active and Passive DNA Hypomethylation

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia
Kirsten Grønbæk 196
Early research (Phase 1)Ended earlyNCT03320642
What this trial is testing

GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease

Who this might be right for
Hematologic Malignancies
Incyte Corporation 84
Testing effectiveness (Phase 2)Study completedNCT05024994
What this trial is testing

E7820 in People With Bone Marrow (Myeloid) Cancers

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesChronic Myelomonocytic Leukemia
Memorial Sloan Kettering Cancer Center 12
Next Page
45